IL144645A0 - Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid - Google Patents

Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid

Info

Publication number
IL144645A0
IL144645A0 IL14464500A IL14464500A IL144645A0 IL 144645 A0 IL144645 A0 IL 144645A0 IL 14464500 A IL14464500 A IL 14464500A IL 14464500 A IL14464500 A IL 14464500A IL 144645 A0 IL144645 A0 IL 144645A0
Authority
IL
Israel
Prior art keywords
fatty acid
nutritional supplement
carbon fatty
triglycerides
pharmaceutical preparation
Prior art date
Application number
IL14464500A
Other languages
English (en)
Original Assignee
Baylor University Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor University Medical Ct filed Critical Baylor University Medical Ct
Publication of IL144645A0 publication Critical patent/IL144645A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL14464500A 1999-02-05 2000-02-03 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid IL144645A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11903899P 1999-02-05 1999-02-05
PCT/US2000/003022 WO2000045649A1 (en) 1999-02-05 2000-02-03 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid

Publications (1)

Publication Number Publication Date
IL144645A0 true IL144645A0 (en) 2002-05-23

Family

ID=22382253

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14464500A IL144645A0 (en) 1999-02-05 2000-02-03 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid

Country Status (14)

Country Link
EP (1) EP1150579B1 (ja)
JP (2) JP4902906B2 (ja)
KR (1) KR100702823B1 (ja)
CN (2) CN101574335A (ja)
AT (1) ATE303079T1 (ja)
AU (1) AU775708C (ja)
CA (1) CA2361070C (ja)
DE (1) DE60022312T2 (ja)
HK (1) HK1042412B (ja)
HU (1) HUP0200511A3 (ja)
IL (1) IL144645A0 (ja)
MX (1) MXPA01007988A (ja)
NZ (1) NZ513329A (ja)
WO (1) WO2000045649A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003160486A (ja) * 2001-09-17 2003-06-03 Lion Corp 経口養育毛剤及び該養育毛剤を含有する飲食品
WO2004022051A1 (ja) * 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. ペルオキシソーム増殖薬活性化受容体調整剤
AU2003261926A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Slimming agents and foods and drinks comprising the same
AU2003261928A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Agents, foods and drinks controlling lipid metabolism
CA2784585A1 (en) 2004-07-02 2006-02-09 Baylor Research Institute Glycogen or polysaccharide storage disease treatment method
EP1929995A1 (en) * 2006-12-04 2008-06-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Anaplerotic therapy of Huntington disease and other polyglutamine diseases
DE102008057867A1 (de) * 2008-11-18 2010-05-20 B. Braun Melsungen Ag Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten
WO2011159634A1 (en) * 2010-06-14 2011-12-22 Baylor Research Institute Triheptanoin diet for adult polyglucosan body disease (apbd) treatment
GB201210699D0 (en) * 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
CN104955450A (zh) 2012-12-13 2015-09-30 达拉斯贝勒研究院 用于治疗葡萄糖转运体1缺乏症的三庚酸甘油酯
WO2015073803A1 (en) 2013-11-14 2015-05-21 The University Of Queensland Neurodegenerative disorders and methods of treatment and diagnosis thereof
MY177028A (en) * 2013-11-14 2020-09-02 Ultragenyx Pharmaceutical Inc Solid compositions of triglycerides and uses thereof
EP3370714A4 (en) * 2015-11-06 2019-07-03 The Children's Hospital of Philadelphia COMPOSITIONS AND METHODS FOR TREATING FATTY ACID METABOLISM DISORDERS
US11844775B2 (en) 2018-07-11 2023-12-19 University of Pittsburgh—of the Commonwealth System of Higher Education Method of treating fatty acid oxidation disorders using Omega3/Omega6 unsaturated or branched chain fatty acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5215834A (en) * 1975-07-12 1977-02-05 Ajinomoto Kk Method of producing food composition
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US5153221A (en) * 1990-10-05 1992-10-06 Elena Avram Method for the treatment of acquired immune deficiency syndrome
US5569675A (en) * 1994-03-07 1996-10-29 Bar Ilan University Methods of using carboxylic acid esters to increase fetal-hemoglobin levels
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CA2263978A1 (en) * 1996-08-27 1998-03-05 Hemosol Inc. Enhanced stimulation of erythropoiesis
US5908631A (en) * 1997-02-27 1999-06-01 L'oreal S.A. Monohydric alcohol-free composition for topical use comprising solubilized ethylcellulose

Also Published As

Publication number Publication date
AU775708C (en) 2005-07-14
KR20010108173A (ko) 2001-12-07
JP2002536304A (ja) 2002-10-29
DE60022312T2 (de) 2006-07-06
JP4902906B2 (ja) 2012-03-21
HK1042412B (zh) 2006-01-06
CA2361070A1 (en) 2000-08-10
CN100408031C (zh) 2008-08-06
MXPA01007988A (es) 2003-07-14
HK1042412A1 (en) 2002-08-16
JP2012082202A (ja) 2012-04-26
DE60022312D1 (de) 2005-10-06
HUP0200511A2 (en) 2002-06-29
HUP0200511A3 (en) 2003-03-28
AU775708B2 (en) 2004-08-12
CN1345188A (zh) 2002-04-17
CN101574335A (zh) 2009-11-11
JP5553815B2 (ja) 2014-07-16
EP1150579A1 (en) 2001-11-07
ATE303079T1 (de) 2005-09-15
WO2000045649A1 (en) 2000-08-10
CA2361070C (en) 2012-04-17
NZ513329A (en) 2003-11-28
EP1150579B1 (en) 2005-08-31
KR100702823B1 (ko) 2007-04-06
AU3223600A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
IL144645A0 (en) Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
CA2382262A1 (en) A nutritional supplement for lowering serum triglyceride and cholesterol levels
EP1174416A4 (en) ESTERS OF CONJUGATED FATTY ACIDS
NZ516101A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
HUP9903791A3 (en) Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters,process for preparing the same and their use in medicaments
TR199700537A2 (xx) Diyete uygun dengelenmi� s�t �r�n�.
HK1020316A1 (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
CA2191645A1 (en) Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
ZA200004725B (en) Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria.
HK1043357B (zh) Lipoxin化合物及其使用
PL1799204T3 (pl) Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6
CA2384859A1 (en) High lipid diet
MY116376A (en) A food for pregnant and lactating women
EP1228708A3 (en) Milk derived basic protein fraction as agents for improving lipid metabolism and reducing high blood pressure
CA2004332A1 (en) Inhibition of cell adhesion
SG162836A1 (en) Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
AU5018900A (en) Lipid metabolism transcription factor
CA2386790A1 (en) Chromium-histidine complexes as nutrient supplements
CA2162042A1 (en) Enteral Nutritional Product
CA2335713A1 (en) Oral dosage form
WO2010133377A8 (en) Fat blends and uses thereof
EP1269991A3 (en) Composition for topical use based on the ethylic ester of linoleic acid and on the triethyl ester of citric acid associated with suitable synergists
AU2003249820A1 (en) Process for increasing the yield of lipid and omega-3 fatty acid in seaweed culture
AU6095399A (en) Food composition based on substance derived from milk comprising conjugate linoleic acid glycerides
EP0087863A3 (en) Pharmaceutical and dietary composition

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: JOURNAL NO. 11/2004 P. 3654 PATENT APPLICATION NO. 144645 CORRECT THE NAME OF APPLICANT TO- BAYLOR RESEARCH INSTITUTE

FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired